![logo](/logos/ARMP.webp)
Armata Pharmaceuticals, Inc.
AMEX:ARMP
2.03 (USD) • At close November 27, 2023
Overzicht | Financiële gegevens
Bedrijfsnaam | Armata Pharmaceuticals, Inc. |
Symbool | ARMP |
Munteenheid | USD |
Prijs | 2.22 |
Beurswaarde | 80,202,606 |
Dividendpercentage | 0% |
52-weken bereik | 0.83 - 5.26 |
Industrie | Biotechnology |
Sector | Healthcare |
CEO | Dr. Deborah L. Birx M.D. |
Website | https://www.armatapharma.com |
An error occurred while fetching data.
Over Armata Pharmaceuticals, Inc.
Armata Pharmaceuticals, Inc., a clinical-stage biotechnology company, focuses on the development of targeted bacteriophage therapeutics for antibiotic-resistant infections worldwide. It develops its products using its proprietary bacteriophage-based technology. The company's product candidates include AP-SA02 for the treatment of Staphylococcus aureus bacteremia; AP-PA02 for Pseudomonas aeruginosa; and AP-PA03 for the treatment
Vergelijkbare Aandelen
Financiële Gegevens
Cijfers zijn in miljoenen (USD)
Cijfers zijn in miljoenen (USD)